Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model.
Publication
, Preprint
Zhang, N; Li, Y; Zhang, X; Chrenek, MA; Wang, J; Girardot, PE; Sellers, JT; Brenner, C; Cui, X; Geisert, EE; Nickerson, J; Boatright, JH
December 4, 2024
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, N., Li, Y., Zhang, X., Chrenek, M. A., Wang, J., Girardot, P. E., … Boatright, J. H. (2024). Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model. https://doi.org/10.1101/2024.12.03.626460
Zhang, Nan, Ying Li, Xian Zhang, Micah A. Chrenek, Jiaxing Wang, Preston E. Girardot, Jana T. Sellers, et al. “Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model.,” December 4, 2024. https://doi.org/10.1101/2024.12.03.626460.
Zhang N, Li Y, Zhang X, Chrenek MA, Wang J, Girardot PE, et al. Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model. 2024.
Zhang, Nan, et al. Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model. 4 Dec. 2024. Pubmed, doi:10.1101/2024.12.03.626460.
Zhang N, Li Y, Zhang X, Chrenek MA, Wang J, Girardot PE, Sellers JT, Brenner C, Cui X, Geisert EE, Nickerson J, Boatright JH. Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model. 2024.